The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.

Monto, Arnold S; Zambon, Maria; Weir, Jerry P

Monto, Arnold S; Zambon, Maria; Weir, Jerry P.

Afiliação

Monto AS; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).
Zambon M; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).
Weir JP; From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor (A.S.M.); the U.K. Health Security Agency, London (M.Z.); and the Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD (J.P.W.).

N Engl J Med ; 390(14): 1256-1258, 2024 Apr 11.

Article em En | MEDLINE | ID: mdl-38416423

Assuntos

Vírus da Influenza B; Vacinas contra Influenza; Influenza Humana; Humanos; Anticorpos Antivirais; Testes de Inibição da Hemaglutinação; Vírus da Influenza A Subtipo H3N2; Vacinas contra Influenza/uso terapêutico; Influenza Humana/prevenção & controle; Influenza Humana/transmissão; Influenza Humana/virologia; Vacinas Combinadas; Vacinas de Produtos Inativados

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vírus da Influenza B / Vacinas contra Influenza / Influenza Humana Limite: Humans Idioma: En Revista: N Engl J Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google